Point72 »

Nurix Therapeutics shares owned by Point72

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Point72 from 13F filings

Historical chart of Point72 investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Point72 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Point72

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.5k 269 9.24
2025-06-30 $33k 2.9k 11.39

More positions owned by Point72

Meta Platforms Cl A (META)
Microsoft Corporation (MSFT)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Boston Scientific Corporation (BSX)
Amazon (AMZN)
Edwards Lifesciences (EW)
Integer Hldgs (ITGR)
Visa Com Cl A (V)
Applied Materials (AMAT)
McKesson Corporation (MCK)
Capital One Financial (COF)
Natera (NTRA)
Sotera Health (SHC)
Dex (DXCM)
Comcast Corp Cl A (CMCSA)

View all positions for Point72

Top funds holding Nurix Therapeutics

FMR
BlackRock
Deep Track Capital
Vanguard Group
Vestal Point Capital
Baker Bros. Advisors
Redmile Group
State Street Corporation
Pictet Asset Management Holding SA
Point72 Asset Management
Deutsche Bank Aktiengesellschaft
Rubric Capital Management
Geode Capital Management
Commodore Capital
Braidwell

View all funds holding Nurix Therapeutics